Skip to content

Amgen AMGN Gross Carrying Amount

Gross Carrying Amount at other companies

Pfizer logo
PfizerPFE
Abbott logo
AbbottABT
Biogen logo
BiogenBIIB
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$184.4B+13.3%
Enterprise value$241.16B+9.9%
P/E23.6×-3.8×
P/S+0.2×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's gross carrying amount?
Amgen (AMGN) reported gross carrying amount of $54.32B in Q1 2026.
How has Amgen's gross carrying amount changed year-over-year?
Amgen's gross carrying amount increased by 0.1% year-over-year, from $54.29B to $54.32B.
What is the long-term trend for Amgen's gross carrying amount?
Over 5 years (2020 to 2025), Amgen's gross carrying amount has grown at a 11.2% compound annual growth rate (CAGR), from $32.02B to $54.35B.